377 related articles for article (PubMed ID: 23114798)
21. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
[TBL] [Abstract][Full Text] [Related]
22. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
[TBL] [Abstract][Full Text] [Related]
23. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
Dager WE; Gosselin RC; Roberts AJ
Crit Care Med; 2013 May; 41(5):e42-6. PubMed ID: 23474679
[TBL] [Abstract][Full Text] [Related]
24. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
25. CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.
Owada S; Tomita H; Kinjo T; Ishida Y; Itoh T; Sasaki K; Horiuchi D; Kimura M; Sasaki S; Okumura K
Thromb Res; 2015 Jan; 135(1):62-7. PubMed ID: 25466835
[TBL] [Abstract][Full Text] [Related]
26. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
Huisman MV; Lip GY; Diener HC; Brueckmann M; van Ryn J; Clemens A
Thromb Haemost; 2012 May; 107(5):838-47. PubMed ID: 22318514
[TBL] [Abstract][Full Text] [Related]
27. Interpretation of point-of-care INR results in patients treated with dabigatran.
van Ryn J; Baruch L; Clemens A
Am J Med; 2012 Apr; 125(4):417-20. PubMed ID: 22306274
[TBL] [Abstract][Full Text] [Related]
28. Dabigatran for stroke prevention in atrial fibrillation.
Hohnloser SH; Diener HC
Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
[TBL] [Abstract][Full Text] [Related]
29. [Dabigatran and emergency operation on a peritonitis patient].
Ilmakunnas M; Louhimo J; Lassila R
Duodecim; 2012; 128(7):753-7. PubMed ID: 22612026
[TBL] [Abstract][Full Text] [Related]
30. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Garza R; Huo MH
Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
[TBL] [Abstract][Full Text] [Related]
31. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
32. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
33. Dental management considerations for a patient taking dabigatran etexilate: a case report.
Romond KK; Miller CS; Henry RG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e191-5. PubMed ID: 23850368
[TBL] [Abstract][Full Text] [Related]
34. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
Faust AC; Peterson EJ
J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114
[TBL] [Abstract][Full Text] [Related]
35. Hemopericardium in a patient treated with dabigatran etexilate.
Barton CA; McMillian WD; Raza SS; Keller RE
Pharmacotherapy; 2012 May; 32(5):e103-7. PubMed ID: 22488474
[TBL] [Abstract][Full Text] [Related]
36. Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
Alonso-Coello P; Zhou Q; Guyatt G
Thromb Haemost; 2012 Oct; 108(4):647-53. PubMed ID: 22918481
[TBL] [Abstract][Full Text] [Related]
37. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
38. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
[TBL] [Abstract][Full Text] [Related]
39. Dabigatran: patient management in specific clinical settings.
Kyrle PA; Binder K; Eichinger S; Függer R; Gollackner B; Hiesmayr JM; Huber K; Lang W; Perger P; Quehenberger P; Roithinger FX; Schmaldienst S; Weltermann A; Domanovits H
Wien Klin Wochenschr; 2014 Sep; 126(17-18):503-8. PubMed ID: 25138549
[TBL] [Abstract][Full Text] [Related]
40. Removal of dabigatran by hemodialysis.
Chang DN; Dager WE; Chin AI
Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]